← FDA DRUG APPROVALS

FDA ANDA · ANDA074120

ATENOLOL

Sponsor: TEVA PHARMS

APPLICATION
ANDA074120
TYPE
ANDA
ORIGINAL APPROVAL
1995-02-24
LATEST ACTION
1999-03-23
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ATENOLOLDiscontinued
ATENOLOL 50MG · TABLET · ORAL
ATENOLOLDiscontinued
ATENOLOL 100MG · TABLET · ORAL

Approval history

1999-03-23Manufacturing (CMC) · Supplement 3AP
1996-11-25Labeling · Supplement 2AP
1996-05-31Manufacturing (CMC) · Supplement 1AP
1995-02-24OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →